Overall (n=165) | Surgical pleurodesis (n=78) | Bedside pleurodesis (n=87) | p Value | |
---|---|---|---|---|
Pleurodesis outcome | ||||
Complete success | 29.7% | 28.2% | 31.0% | p=0.82 |
Partial success | 38.8% | 39.7% | 37.9% | p=0.94 |
Failure | 31.5% | 32.1% | 31.0% | p=0.98 |
Demographics | ||||
Mean (SD) age | 69.9 (10.5) | 67.1 (10.4) | 72.3 (10.5) | p=0.001 |
Male | 86.7% | 83.3% | 89.7% | p=0.34 |
Survival in days (diagnosis to death) | 443 (197–743) | 410 (186–753) | 455 (197–743) | p=0.52 |
Days from diagnosis to pleurodesis | 17 (0.0–63.0) | 0.0 0.0–29.5) | 54.0 (9.0–121.0) | p<0.001 |
Subtype | ||||
Epithelioid | 86 | 40 | 46 | p=0.21 |
Sarcomatoid | 9 | 8 | 1 | |
Biphasic | 30 | 19 | 11 | |
Unclassified* | 40 | 11 | 29 | |
Hospital admissions (episodes) | 6.0 (2.0–9.0) | 5.0 (2.0–9.0) | 6.0 (2.5–9.0) | p=0.51 |
Hospital admissions (total days from diagnosis) | 20.0 (12.0–31.0) | 19.0 (12.0–28.0) | 23.0 (13.0–35.0) | p=0.36 |
Hospital admissions (total days expressed as % of remaining lifespan spent) | 5.1% (2.1–10.9%) | 4.9% (2.1–12.1%) | 5.1% (2.1–10.3%) | p=0.96 |
*Patients with no histological subtypes defined (usually diagnosed by pleural fluid cytology).